Best Tools for Gut Health & Weight Loss | Dr. Chris Thompson
This discussion with Dr. Chris Thompson, an interventional gastroenterologist and obesity-medicine expert at Harvard/Mass General Brigham, explains how the digestive tract, gut hormones, microbiome, metabolism, and body weight are deeply connected. The central practical message is that fiber, fermented foods, resistance training, cardio, and earlier metabolic monitoring support gut and metabolic health, while medications and procedures can provide important additional tools when needed. The conversation also looks ahead to targeted endoscopic treatments, AI-guided procedures, and gene therapy designed to work more closely with normal physiology.
1. The Gut Is More Than a Food Tube
Dr. Thompson begins by framing the gastrointestinal tract as much more than a simple passageway for food. It digests and absorbs nutrients, but it is also an endocrine organ—meaning it releases hormones that affect hunger, fullness, insulin, blood sugar, and metabolism. This is one reason people sometimes refer to it as a "second brain."
The digestive system is divided into sections, each with a specialized function:
- The esophagus safely transports swallowed food into the stomach.
- The stomach stores, churns, acidifies, and gradually releases food.
- The small intestine performs most calorie and nutrient absorption.
- The colon absorbs water and houses much of the gut microbiome, which produces important metabolic compounds.
The esophagus moves food downward through coordinated muscular contractions. Problems can occur when its lower muscle fails to relax, as in achalasia, causing food to get stuck, pressure in the chest, regurgitation, and sometimes vomiting.
"The esophagus… [is] just kind of moving the food into the stomach safely."
Chronic acid reflux is another concern. Over time, reflux can damage the esophageal lining, create scar tissue that narrows the passage, or contribute to Barrett's esophagus, a precancerous condition that requires monitoring.
The stomach begins preparing for a meal even before food arrives. The smell, sight, or anticipation of food can cause it to relax and expand to accommodate what is coming. The upper stomach, called the fundus, acts as a reservoir; the main body grinds food; stomach acid helps break it down; and the lower stomach gradually releases it into the duodenum, the first segment of the small intestine.
"When you start to smell food, it starts stretching and becoming more like a bag."
The stomach also releases ghrelin, often called the hunger hormone. Problems with stomach emptying, such as gastroparesis, can lead to nausea, vomiting, and discomfort. Diabetes, viral illness, neural factors, and hormonal factors can all contribute.
2. The Small Intestine, Colon, and Cancer Screening
The small intestine is where most calories are absorbed. Its lining is only one cell thick, yet it has an enormous surface area—compared here to a pickleball court. This thin barrier must allow nutrients in while keeping harmful material out.
That barrier is supported by several layers:
- Enterocytes, the absorptive intestinal cells
- Goblet cells, which produce protective mucus
- Tight junctions, protein structures that seal spaces between cells
- Immune cells and other protective components
"It is one cell layer thick. So that's why the stomach [and] the esophagus [have] a good job of processing that food so that it's safe to go down through the small bowel and be absorbed."
Conditions such as celiac disease and Crohn's disease can damage the small intestine. Dr. Thompson also emphasizes emerging research suggesting that the small intestine plays a central role in obesity, diabetes, insulin resistance, and metabolic disease.
By the time food reaches the colon, most nutrients have already been absorbed. The colon's basic physical role is water absorption, but it also has major hormone and microbiome-related functions. Gut microbes in the colon ferment fiber and generate short-chain fatty acids, especially butyrate. Butyrate supports colon cells, gut-barrier integrity, satiety signaling, and metabolic health.
The colon also produces substantial GLP-1, a hormone now widely recognized because of GLP-1 medications for diabetes and weight loss.
Dr. Thompson strongly emphasizes colorectal cancer screening. In the United States, average-risk screening now generally begins at age 45, though people with a family history may need earlier screening—often at age 40 or 10 years before the age when their relative was diagnosed, depending on individual circumstances.
Common screening options include:
- Colonoscopy, typically every 10 years if normal.
- Stool-based screening tests, such as Cologuard, repeated more frequently.
- In some settings, CT colonography or other tests.
Screening matters because it can find polyps or early cancer when treatment is easier. Modern endoscopic techniques can sometimes remove early cancers or precancerous tissue without removing part of the colon.
"You can have the colonoscopy to remove the lesion… You don't have to actually remove a piece of the colon anymore."
3. Swallowing, Bowel Movements, and Warning Signs
Food occasionally coming back through the nose during eating can reflect a swallowing-coordination problem. This may involve the throat, upper esophageal sphincter, or age-related changes in swallowing mechanics. Some people benefit from working with a speech-language pathologist, who can teach specific swallowing positions, strategies, and food-texture modifications.
A more structural cause is Zenker's diverticulum—a pouch near the upper esophagus that traps food. Food can return to the mouth or nose, and the pouch can create coughing, discomfort, and aspiration risk.
"The problem is when people then aspirate and that food goes in the lung… eventually it can really cause problems."
Dr. Thompson says swallowing difficulties should not simply be dismissed as odd or inconvenient. They deserve medical evaluation, especially if food is getting stuck, returning repeatedly, or causing coughing and choking.
The conversation then turns to bowel movements, which are useful but often overlooked indicators of health. A general rule of thumb offered in the discussion is:
- Not more than three bowel movements per day
- Not more than three days without a bowel movement
- Ideally, stools should generally be formed rather than tiny, hard pellets
Small, pebble-like stools—called scybalous stools—often suggest constipation and insufficient fiber intake. Dark, tarry, shiny stool can be a sign of bleeding higher in the GI tract and should be taken seriously.
"There's so much you can tell from bowel movements."
The broader point is not that everyone must have exactly the same bowel pattern, but that changes from one's usual pattern, persistent constipation, diarrhea, blood, black stools, unexplained weight loss, or pain deserve attention.
4. Fiber Feeds the Microbiome
One of the strongest practical messages in the episode is the importance of dietary fiber. Dr. Thompson notes that many people in Western countries fail to consume enough of it. A commonly discussed target is around 35 grams daily for adult men and 25 grams for adult women, though individual needs, tolerance, body size, and medical conditions vary.
Fiber is not merely about making bowel movements more regular. Research discussed in the episode links certain forms of fiber, including resistant starch, to improved metabolic outcomes. In studies mentioned by Dr. Thompson, resistant starch type 2 was associated with improvements in fatty liver and insulin sensitivity.
The microbiome relies heavily on fiber. Gut microbes ferment it, producing short-chain fatty acids such as butyrate. Butyrate helps feed colon cells, supports tight junctions, maintains the mucus barrier, and may influence GLP-1 and satiety pathways.
Dr. Thompson gives the episode's most memorable warning:
"Feed your microbes, or they're going to eat you."
More specifically, if microbes do not receive enough dietary fiber, they may begin consuming the gut's protective mucus layer instead. This weakens the barrier, reduces beneficial butyrate production, and can create a cascading problem.
"What they eat is fiber. Okay? That's what you want them eating."
"If you're not feeding them fiber, they'll eat your mucus layer."
"It's like a snowball effect that if you're not feeding the microbiome and keeping it healthy, you're going to run into all sorts of trouble."
Huberman shares that adding powdered psyllium husk made him feel better after meals rather than bloated. The speakers acknowledge that some people can initially experience gas or bloating as they increase fiber, but this does not mean fiber is inherently harmful. Gradually increasing intake and drinking adequate fluids may help people tolerate it better.
5. Fasting and Fermented Foods
The discussion addresses whether intermittent fasting might harm the microbiome because the gut is empty for longer periods. Huberman mentions the idea that microbes may consume more of the gut's mucus layer during fasting, but Dr. Thompson does not view this as a major reason to avoid time-restricted eating.
Instead, he believes the likely metabolic benefits of intermittent fasting or time-restricted eating generally outweigh that theoretical concern for many people. Giving the body intervals without food may allow insulin levels to come down and reduce the metabolic burden of near-constant eating.
"The benefits of intermittent or time-restricted eating… probably would outweigh that risk."
He notes that eating earlier in the day and beginning the fasting window in the afternoon may potentially be advantageous, although he personally also often skips breakfast. The main message is that a consistent eating window is likely more useful than continually grazing throughout the day.
The speakers then discuss low-sugar fermented foods, such as:
- Kefir
- Yogurt
- Kimchi
- Sauerkraut
- Kombucha
- Other cultured foods
Fermented foods may be helpful because they contain both prebiotic elements, which feed microbes, and some probiotic organisms, meaning live microbes. They may also be partly "pre-digested," making nutrients more accessible.
A study referenced in the conversation found that fermented foods increased microbial diversity and lowered inflammatory markers. Fiber had its own benefits, but fermented foods appeared especially useful for microbial diversity in that particular research.
"It's sort of like when you're trying to grow something, you want to plant the seeds but also have the fertilizer… This is what fermented foods do for you."
The speakers stress that butyrate itself is not easily replaced with a simple supplement. It needs to be generated in the colon through the coordinated activity of gut microbes. Some bacteria break fiber into compounds such as acetate and lactate; other bacteria use those products to produce butyrate. This is called microbial cross-feeding.
"The butyrate is magical."
Butyrate helps feed colon cells, strengthen tight junctions, influence satiety signaling, and keep the colon more acidic—an environment that can discourage certain unwanted microbes.
6. Ulcers, H. pylori, and Stress
The discussion clarifies an important nuance about ulcers. Helicobacter pylori (H. pylori) is a bacterium that can cause stomach ulcers, and its discovery transformed medicine. Barry Marshall famously helped prove this by ingesting the bacterium himself after others doubted the idea.
"No one believed him. He had to consume it himself… and then he had gastric ulcers."
However, finding that H. pylori can cause ulcers does not mean all ulcers are caused by one bacterium or that stress is irrelevant. Stress, smoking, impaired blood flow, acid exposure, certain medications, and anatomical changes after gastric bypass can all contribute.
"One thing can cause something; it doesn't mean it's always the case."
Dr. Thompson explains that ulcers often result from multiple hits: for example, acid exposure combined with reduced tissue blood flow or impaired protective mechanisms. Stress may increase acid production and exacerbate vulnerability, but the details depend on the person and the setting.
7. GLP-1 Drugs: Powerful but Not Perfect
The conversation then turns to GLP-1 receptor agonist medications, including semaglutide- and tirzepatide-type drugs. Dr. Thompson is clear that these drugs are valuable tools for treating obesity and its associated metabolic risks.
"I'm grateful we have them."
"They're not perfect… but it's much better to have them than not have GLP-1s."
Still, many people discontinue them. Dr. Thompson cites high discontinuation rates, including substantial numbers stopping within the first month and around half stopping within a year. Reasons may include:
- Nausea and other side effects
- Injection fatigue
- Cost
- Difficulty reaching or tolerating higher doses
- Concern about long-term use
- Feeling that the medication stops working
- Muscle loss or changes in body composition
A key concern is lean-mass loss. With some earlier GLP-1 medications, a meaningful portion of lost weight may come from lean tissue, including muscle. If someone repeatedly stops the drug, regains fat, restarts it, and loses more muscle, their body composition can worsen over time.
"You're not putting the lean mass back on… You're putting the fat back on."
"There has to be a game plan."
Dr. Thompson discusses clinician-guided, individualized lower-dose maintenance strategies—sometimes informally called "microdosing"—as an area people are exploring. The central idea is that some patients may benefit from finding the lowest effective dose rather than automatically following a one-size-fits-all dose escalation. However, this should be medically supervised; medication handling, dosing, and injection practices carry real safety considerations.
Resistance training is essential during any significant weight-loss process, whether through drugs, surgery, endoscopic procedures, or dietary change.
"If you're doing resistance training, you tend to maintain your muscle because the body realizes, 'Hey, I need this muscle.'"
For people at elevated risk of low muscle mass, Dr. Thompson suggests assessing body composition—potentially with a DEXA scan—and taking muscle preservation seriously before beginning treatment.
The most common complaints he hears from patients are nausea at higher doses and noticeable muscle loss. Reports of apathy, reduced interest in food or alcohol, and rare eye complications are also discussed, but the speakers emphasize distinguishing genuine risks from exaggerated social-media narratives.
8. Hunger Hormones and Why Processed Foods Promote Overeating
The gut's hunger and fullness system involves many hormones—not just GLP-1.
Key hunger and satiety signals
- Ghrelin: Primarily produced in the stomach fundus; rises before meals and promotes hunger.
- CCK: Released early in the small intestine; helps stimulate bile release and contributes to fullness.
- GIP: An incretin hormone that works alongside GLP-1 and may help with insulin sensitivity and nausea reduction in combination therapies.
- GLP-1: Released in response to nutrients; helps insulin release, slows stomach emptying, and increases fullness.
- Peptide YY (PYY): Often stimulated by protein and fat; contributes to prolonged fullness.
- Leptin: Produced by fat tissue; helps signal long-term energy stores and influences the body-weight "set point."
Ghrelin rises with fasting and falls after eating. CCK, PYY, GIP, and GLP-1 increase after nutrients move further through the gut. The body is therefore not governed by one hunger switch—it is a dynamic, multi-hormone system.
"Ghrelin is the hunger hormone."
"GLP-1 and GIP [are] like Batman and Robin."
The newer investigational drug retatrutide combines activity at GLP-1, GIP, and glucagon receptors. Dr. Thompson explains that adding GIP may help improve tolerability and insulin sensitivity, while glucagon may support fat burning and potentially preserve muscle better than a GLP-1-only approach.
The speakers use this as an example of a broader principle: manipulating several systems moderately may work better than pushing one pathway to extremes.
Highly processed foods are another major issue. A study mentioned in the episode found that when people were allowed to eat ultra-processed foods freely, they consumed roughly 500 additional calories per day compared with when they ate whole foods.
These foods may encourage overeating because they are easier to consume, lower in fiber, rapidly digested, and often produce larger glucose swings. They may also have a lower thermic effect of food, meaning the body uses less energy digesting and processing them.
"If you're eating stuff in a wrapper… you're inclined to eat more of it."
Leptin was once hoped to be a simple cure for obesity. But many people with obesity already have high leptin levels and develop leptin resistance—the brain becomes less responsive to the signal. Chronic inflammation may be one contributor.
9. The Discovery of Incretins and GLP-1
The episode offers a short scientific history of the incretin effect. Researchers discovered that the body produces more insulin when glucose is consumed orally than when the same amount is delivered intravenously. This implied that the gut releases signals that amplify insulin secretion after eating.
Early researchers suspected a gut-derived hormone because the duodenum was already known to make secretin, which signals the pancreas to release digestive fluids. They began looking for other gut hormones that might influence blood sugar.
"They gave subjects a set amount of glucose intravenously… Then they gave them the exact same amount orally and they found they produced much more insulin."
Eventually, scientists identified GLP-1 as an important incretin. But natural GLP-1 breaks down extremely quickly because of an enzyme called DPP-4, making it difficult to use as a medication.
A breakthrough came from studying Gila monster venom, which contains exendin-4, a molecule similar to GLP-1 but more resistant to breakdown. This discovery helped lead to modern GLP-1 medications.
"This is what ends up becoming all the GLP-1s."
The story illustrates how basic biology, animal research, chemistry, and clinical medicine can unexpectedly combine to create major treatments.
10. Earlier Metabolic Detection
Dr. Thompson argues that people should not wait until hemoglobin A1C is high enough to indicate diabetes before paying attention to metabolic health. He describes a typical progression of metabolic dysfunction:
- Excess calorie intake, often involving highly refined carbohydrates and frequent eating.
- Increased glucose spikes.
- Chronically elevated insulin, especially fasting insulin.
- Accumulation of visceral fat and ectopic fat—fat deposited in organs and tissues not designed to store it, such as the liver, pancreas, and muscle.
- Insulin resistance.
- Metabolic inflexibility—difficulty switching between burning fat during fasting and burning carbohydrates after meals.
- Greater likelihood of weight gain, beta-cell dysfunction, and diabetes.
"There are signs much, much earlier than [hemoglobin A1C]."
He recommends considering several earlier measurements, under appropriate medical guidance:
- Continuous glucose monitor (CGM): Used temporarily to learn which meals, sleep patterns, stressors, or behaviors create large glucose spikes.
- Fasting insulin: An inexpensive test that may identify risk long before diabetes develops.
- Waist circumference or waist-to-height ratio.
- DEXA scan or imaging when appropriate to assess visceral fat.
- ALT and other liver markers to screen for liver inflammation or fatty liver.
- Calculated measures of insulin resistance using fasting glucose and fasting insulin.
- Breath-based metabolic testing, which measures oxygen and carbon dioxide exchange to estimate whether the body is burning more fat or carbohydrate.
The Whitehall II study is cited as evidence that elevated fasting insulin can predict later diabetes many years in advance. Dr. Thompson also points out that being lean does not automatically mean being metabolically healthy.
"Less than a third of people that are lean are metabolically healthy."
The discussion acknowledges that more data can sometimes create anxiety or lead to unnecessary follow-up tests. But Dr. Thompson favors sensible earlier detection, especially when the information can help someone make practical changes before irreversible damage occurs.
"Why not learn about yourself, take some responsibility, and prevent these diseases from going on?"
11. Procedures, AI, and Precision Medicine
Dr. Thompson describes how his career began with endoscopic ultrasound, a procedure in which a scope enters through the mouth and uses ultrasound imaging from inside the digestive tract. This makes it possible to see nearby organs, including the pancreas, and perform targeted biopsies without open surgery.
His early work involved improving pancreatic biopsy needles. Standard needles were designed to pass through tissue gently, not to collect intact tissue samples. By working with engineers, he helped develop a needle that could obtain better tissue architecture, improving diagnosis and enabling more precise testing of tumors.
"You needed a team to fix it."
The broader lesson is that medical innovation often emerges when clinicians identify a real problem, engineers develop tools, researchers validate them, and teams work through regulatory and safety requirements.
The episode also explores AI-guided surgery and endoscopy. AI may eventually help clinicians by:
- Highlighting structures such as blood vessels
- Suggesting suture placement
- Measuring stitch quality and spacing
- Modeling expected changes in stomach shape
- Identifying suspicious lesions
- Giving objective procedure-quality feedback
"AI can actually coach you through procedures."
Robotics may reduce the learning curve for technically difficult procedures. In training studies discussed by Dr. Thompson, novices using robotic systems could perform some complex tasks much closer to expert level than they could with traditional tools.
However, technology is not a substitute for judgment. AI is trained on many prior cases and can recognize patterns, but the physician still makes the final decisions.
"You're not using this AI blindly. You're using your clinical judgment."
When choosing a surgeon or proceduralist, Dr. Thompson recommends considering case volume, including both current volume and cumulative experience. He also argues for more transparent, objective quality metrics, such as complication rates, technical measurements, and patient outcomes.
12. Gut Permeability, Fatty Liver, and Inflammation
The term "leaky gut" can frustrate physicians because it is often used vaguely or blamed for every possible symptom. But Dr. Thompson clearly states that increased intestinal permeability is real.
"Increased gut permeability is 100% real."
The issue is whether people use "leaky gut" to mean a specific measurable barrier problem—or as a catch-all explanation for unrelated conditions.
In people with obesity, fatty liver disease, or MASH—metabolic dysfunction-associated steatohepatitis—research has found evidence of impaired tight junctions. Their intestinal cells may produce fewer of the proteins needed to form strong barriers, and the junctions can be more disorganized.
When the intestinal barrier is weakened, bacterial products such as lipopolysaccharide (LPS) can cross into circulation. Since blood from the gut first travels to the liver through the portal circulation, the liver is especially exposed. LPS can trigger inflammatory pathways and may contribute to insulin resistance.
"If you don't have tight junctions, it stands to reason you might have quote-unquote leaky gut."
Dr. Thompson refers to studies in which researchers used tracers that normally should not cross the gut lining. These tracers appeared in the blood at higher levels in people with fatty liver disease, supporting the idea of impaired barrier function.
This returns the conversation to the earlier discussion of fiber and fermented foods: a healthier microbiome, mucus layer, butyrate production, immune system, and tight junction network all work together.
"The microbiome and that butyrate [are] critical to producing healthy… tight junctions [and] a healthy mucin layer."
Still, Dr. Thompson cautions against blaming gut permeability for everything.
"Absolutely [it] is a problem. It's just I don't want to blame it for everything."
13. Sweeteners, Fructose, Fats, and Omega-3s
On artificial sweeteners, Dr. Thompson takes a relatively measured position. He sees them as likely preferable to large amounts of high-fructose corn syrup, but he does not present them as health foods. One complication is that artificial sweeteners often occur in highly processed foods, making it hard to isolate their independent effects.
Fructose in whole fruit is not the same as fructose in sweetened drinks. Fruit comes with fiber and a food matrix that slows absorption. Sugary beverages deliver fructose rapidly to the liver, which is the main organ that processes it.
"Fructose in fruit is fine… It comes with a matrix around it."
"Fructose can only be processed by the liver."
The conversation also covers fats. Both speakers favor olive oil as a reliable choice and view small amounts of butter as reasonable in the context of an overall healthy diet. Dr. Thompson argues that polyunsaturated fats are not inherently harmful; concerns may arise when oils are oxidized, stored poorly for long periods, exposed to heat repeatedly, or used for repeated deep frying.
"You don't want to take an oxidized oil into your body."
On omega-3s, he sees the data as mixed for universal supplementation. His general approach is to identify genuine deficits and correct them rather than assuming every supplement is necessary for everyone. Fatty fish a couple of times per week can be a useful food source, while algae-derived omega-3s offer an option for vegetarians.
14. Exercise, Set Point, and Sustaining Weight Loss
Dr. Thompson recommends three broad forms of exercise for people trying to improve metabolic health or maintain weight loss:
- Resistance training to preserve or build muscle.
- Zone 2 cardio to support aerobic capacity and fat oxidation.
- High-intensity interval training (HIIT) to mobilize visceral fat and improve fitness.
"All my patients, I ask them to do resistance training… It's essential."
He explains that visceral fat is responsive to stress hormones and can be mobilized during intense exercise. During the workout itself, people may primarily burn carbohydrates and glycogen, but HIIT can still help mobilize visceral fat over time.
The challenge is that weight loss triggers biological compensation. The body has a defended weight range—often called a set point, though Dr. Thompson prefers thinking of it as a defended range. After crash dieting, people may experience:
- Higher ghrelin and hunger
- Lower GLP-1, PYY, CCK, and satiety signals
- Reduced resting energy expenditure
- Greater muscle efficiency, meaning fewer calories burned for the same activity
- Lower non-exercise activity
- Strong pressure to regain weight
The famous follow-up research on The Biggest Loser is mentioned as an example: participants showed major metabolic adaptation, including burning hundreds fewer calories daily than expected after weight loss.
"Your whole body is fighting you."
This is why diet and exercise alone can be difficult for some people—not because they are irrelevant, but because the body's hormonal and metabolic adaptations actively resist long-term loss.
"That doesn't mean it's irrelevant."
Whether someone uses medication, surgery, an endoscopic procedure, or none of these, the underlying behaviors still matter:
- Eat more fiber-rich whole foods.
- Reduce frequent glucose and insulin spikes.
- Limit ultra-processed foods.
- Move regularly.
- Build and preserve muscle.
- Address sleep, stress, and other contributors where possible.
"The treatments will fail unless you really address those underlying problems."
15. Endoscopic Weight-Loss Procedures
Dr. Thompson explains how bariatric procedures evolved. Early surgeries focused on creating malabsorption by bypassing large portions of the intestine, but some created dangerous complications. Gastric bypass and other operations were initially thought to work primarily by restriction—making the stomach smaller—and by reducing calorie absorption.
Over time, researchers realized these procedures also change gut hormones, stomach emptying, hunger signals, and glucose regulation.
One procedure developed by Dr. Thompson's group is endoscopic sleeve gastroplasty (ESG). Instead of surgically removing part of the stomach, clinicians enter through the mouth and use internal sutures to fold and reduce the stomach's functional volume.
The goal is not only mechanical restriction. ESG may also:
- Create earlier stretch signaling, helping the brain register fullness.
- Slow gastric emptying.
- Suppress ghrelin because food remains in the stomach longer.
"When food hits [the smaller stomach], the stomach stretches quicker… you tell the brain, 'We're full.'"
"The other part of it is you suppress ghrelin."
Because ghrelin suppression may counter one of the body's major weight-regain mechanisms, this may help support longer-term maintenance for some patients.
Researchers are also exploring fundus ablation, which targets ghrelin-producing cells in the upper stomach. Combining this with ESG may potentially improve weight loss further, though such approaches remain specialized and require proper medical assessment.
The larger vision is to personalize obesity care. One person may primarily struggle with hunger driven by ghrelin, another with insulin resistance, another with altered gut signaling, and another with multiple issues. The future may involve identifying the dominant mechanism and applying the least invasive treatment that can effectively address it.
"Maybe they just have ghrelin that's driving them—just ablate the ghrelin."
16. Duodenal Treatments and Combined Approaches
A major area of Dr. Thompson's research concerns the duodenum, the first part of the small intestine. His interest began after treating a patient who regained weight and diabetes after gastric bypass. The patient had developed a small connection, or fistula, between the newly created stomach pouch and the excluded older stomach.
Closing this fistula relieved reflux, but it also led to weight loss and rapid improvement of diabetes. This unexpected result suggested that excluding food from certain upper-intestinal areas might strongly affect metabolic signaling.
"The reflux stopped, but the person started losing weight and their diabetes went away almost immediately again."
Animal research also suggested that foregut exclusion—reducing food exposure to the duodenum and early jejunum—can improve diabetes independently of weight loss. This raised the possibility that the upper intestine produces signals that may worsen metabolic disease under certain conditions.
Several approaches are discussed:
Duodenal liners
A sleeve-like device can be placed inside the upper intestine. Food travels inside the liner while digestive juices flow outside it, delaying their mixing. In trials, this approach improved A1C and produced moderate weight loss, but the device must eventually be removed.
Duodenal mucosal resurfacing
Another approach uses heat, steam, or another form of controlled ablation to remove and regenerate the duodenal lining. The idea is that overfeeding and metabolic disease may produce a "sick" duodenum—with inflammation, longer villi, altered nutrient absorption, and impaired barrier function.
After treatment, the duodenal lining regenerates. In studies described by Dr. Thompson, A1C reductions of more than one point have been observed, even without major weight loss.
"You don't reroute any bowel. You just ablate the duodenum."
"It regenerates… [and] comes back more healthy and more normal."
The discussion emphasizes that these treatments are still evolving. They are not simple universal replacements for medication or lifestyle change, but potentially useful additional tools—especially for diabetes and for preventing weight regain after stopping GLP-1 drugs.
Magnetic intestinal connections
Dr. Thompson's team also developed methods using paired magnets to create a connection, or anastomosis, between different sections of the small intestine. This can allow food to reach the lower intestine sooner, stimulating larger GLP-1 responses.
When such lower-intestinal delivery is combined with stomach-reduction procedures, the overall effect may resemble some benefits of gastric bypass: greater fullness, reduced ghrelin, altered nutrient flow, and increased GLP-1 signaling.
"You're getting really amazing weight loss."
The central principle is not simply "make the stomach smaller" or "use more GLP-1." It is to use multiple biological levers—carefully and precisely—rather than relying excessively on one.
"You can mitigate risk by… not giving too much of one thing."
17. Gene Therapy for Nutrient-Responsive GLP-1
One of the most futuristic topics is possible GLP-1 gene therapy. Current GLP-1 medications produce sustained, high, non-physiological hormone exposure. They can be highly effective, but they do not mimic the body's normal pattern of releasing small amounts of GLP-1 after eating.
Researchers are investigating whether a viral vector could place a GLP-1 gene into pancreatic beta cells. The genetic construct would use an insulin-responsive promoter, meaning that when beta cells release insulin in response to nutrients, they would also release GLP-1.
"When a patient would secrete insulin in a nutrient-responsive way, [they would] simultaneously be secreting GLP-1."
The vector could potentially be injected into the pancreas using endoscopic ultrasound, the same technology used for pancreatic biopsies. The therapy would be targeted to beta cells and designed to remain active there rather than circulating broadly throughout the body.
This could create a more physiologically timed GLP-1 signal—released with meals, where and when it is most useful.
"You're making it at the place where it's needed, right at the pancreas."
Animal studies discussed in the episode found that this approach caused weight loss and appeared to help prevent regain after stopping semaglutide. The treatment has entered early clinical trials, but it remains experimental. Its ultimate role may be more useful for diabetes, obesity, or as an add-on to other therapies; much remains to be learned.
18. Innovation Is a Team Effort
The conversation closes with a reflection on Dr. Thompson's approach to medicine. He describes himself as someone who has always liked to tinker, build, and solve problems with his hands. He chose interventional gastroenterology partly because he wanted not merely to manage decline, but to find ways to physically and biologically change a disease process.
"I needed to solve problems with my hands."
He argues that medicine should keep asking whether it is treating only a number—such as high LDL cholesterol, blood pressure, or blood sugar—or addressing the underlying drivers of disease. Medications can be life-saving and necessary, but he believes the long-term goal should be to combine them with better prevention, earlier diagnosis, lifestyle fundamentals, and targeted procedures.
"We need to address the underlying problem."
Huberman praises Dr. Thompson's willingness to improve existing tools rather than assuming current solutions are enough. Dr. Thompson responds by emphasizing that innovation is never the achievement of one person alone.
"Everything is a team effort."
"Innovation is never the result of one person's work. It's a whole group."
Conclusion
The episode's most actionable lesson is that gut health and metabolic health are inseparable. Prioritize fiber-rich whole foods, include fermented foods if tolerated, avoid constant eating and excessive ultra-processed foods, preserve muscle through resistance training, use cardio strategically, and consider earlier measurement of glucose and insulin regulation.
For people dealing with obesity, diabetes, or significant GI symptoms, the discussion also offers a hopeful message: there are increasingly many evidence-based tools—from medications and endoscopic procedures to emerging AI and gene therapies. The future of treatment is likely to be more personalized, multi-layered, and physiology-based, rather than relying on a single drug or a single procedure.
Need a summary like this?
Get instant summaries with Harvest